Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement

NCT04062695 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Psoriatic Arthritis
Spondylitis
Sacroilitis

Interventions

DRUG: Tofacitinib 5 MG Oral Tablet [Xeljanz]
DRUG: Placebo oral tablet

Sponsor

Charite University, Berlin, Germany